Other — Net Sales
West Pharmaceutical Services Other — Net Sales remained flat by 0.0% to $88.33M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.2%, from $84.75M to $88.33M. Over 4 years (FY 2021 to FY 2025), Other — Net Sales shows relatively stable performance with a -0.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful market expansion or higher demand in secondary international territories, while a decrease may signal competitive pressure or economic headwinds in those specific regions.
Detailed definition
This metric represents the total revenue generated from external customers within the 'Other' geographic segment, exclud...
Peer comparison
Peers typically report geographic revenue splits; this metric is comparable to 'Rest of World' or 'Other International' revenue lines in global manufacturing firms.
wst_segment_other_net_salesHistorical Data
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $357.40M | $364.30M | $348.50M | $339.00M | $353.30M |
| YoY Change | — | +1.9% | -4.3% | -2.7% | +4.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's other — net sales?
- West Pharmaceutical Services (WST) reported other — net sales of $88.33M in Q4 2025.
- How has West Pharmaceutical Services's other — net sales changed year-over-year?
- West Pharmaceutical Services's other — net sales increased by 4.2% year-over-year, from $84.75M to $88.33M.
- What is the long-term trend for West Pharmaceutical Services's other — net sales?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's other — net sales has grown at a -0.3% compound annual growth rate (CAGR), from $357.40M to $353.30M.
- What does other — net sales mean?
- Total revenue generated from sales in geographic regions categorized as 'Other'.